Denmark-based Lundbeck cannot recover damages for the alleged infringement of its Lexapro patent by generic drug companies that it dropped its claims against, a judge has found.
The Full Federal Court has shot down a challenge by Japanese electronics company Nichia Corp. to a ruling that Arrow Electronics did not infringe its patent for a white light emitting device.
The Australian Taxation Office has successfully appealed an Administrative Appeals Tribunal decision in favour of BHP Billiton, leaving the mining giant with a hefty $82 million tax bill over its Singapore marketing hub.
The Australia Competition and Consumer Commission is seeking a $35 million penalty against Empower Institute after the court found the vocational trainer engaged in unconscionable conduct by “duping” customers into enrolling in courses they could not afford.
A key prospective witness in the Ben-Roberts Smith defamation proceedings can continue to have her identity suppressed, after a judge found there was “sufficient risk” to her safety if it was revealed.
The Fair Work Ombudsman is suing a sushi operator in a case which will, for the first time, utilise laws that put the onus of proof on employers to disprove underpayment allegations.
Juno Pharmaceuticals has resolved its appeal of an IP Australia ruling that allowed Seattle-based Juno Therapeutics to extend protection of its namesake trade mark into Australia.
The Australian Securities and Investments Commission has called for the big accounting firms to focus on “culture and talent” after a new report found one in five audits had no reasonable basis for clearing company financial reports of material misstatements.
Teva has taken generic drug maker Pharmacor to court for allegedly threatening to infringe its patent for a Parkinson’s drug.
International law firm Jones Day has expanded its intellectual property team in Sydney, hiring experienced patent litigator Andrew Rankine from Ashurst as its second local partner.